Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia-Reference-Cited by-同舟云学术

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia

Published:2019-01 Issue:1 Volume:70 Page:33-39
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Iversen Jenny,Dore Gregory J.,Catlett Beth,Cunningham Philip,Grebely Jason,Maher Lisa

Funder

Australian Government Department of Health

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Hepatitis C virus therapeutic development: in pursuit of “perfectovir”;Dore;Clin Infect Dis,2015

2. Combating hepatitis B and C to reach elimination by 2030;World Health Organization,2016

3. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

5. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden;Harm Reduction Journal;2023-06-12

2. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs;Value in Health;2023-06

3. Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study;International Journal of Drug Policy;2023-06

4. Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study;Addiction Science & Clinical Practice;2023-05-25

5. HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers;International Journal of Drug Policy;2023-03